Bayani Pocholo Maglinte
Post-Residency Fellow, Preventive Cardiology, Hypertension and Lipidology
STUDENT/TRAINEE
Member Since: 2026
Original Join Date: 2026
Professional Bio
Bayani Pocholo T. Maglinte, MD, FPCP is a Filipino physician specializing in Internal Medicine with ongoing subspecialty training in Cardiovascular Disease Prevention, Hypertension, and Lipidology. He is currently a Medical Honorary Rotator at the Hypertension Clinic, Vascular Research Clinics, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, UK, and serves as a Hypertension Fellow at the Section of Cardiac Prevention, Hypertension and Lipidology, Division of Cardiovascular Medicine, UP–Philippine General Hospital.
A Board-Certified Internist and Fellow of the Philippine College of Physicians, he is a member of the Philippine LIFECARE Study Group, the European Society of Hypertension, and the Philippine Lipid and Atherosclerosis Society, and is an alumnus of the BIHS Emerging Hypertension Leaders Programme (Cambridge, 2025).
His research spans cardiometabolic epidemiology, acute heart failure, hypertension, dyslipidemia, and clinical outcomes research in Philippine tertiary hospital settings. He has authored and co-authored over 15 studies and has received recognition including the PCP INSPIRE 2026 Most Outstanding Research Award and the APSAVD 2026 Young Investigator Award — both for his work on body shape index and cardiometabolic risk in the Philippine LIFECARE cohort.
He also serves as an Evidence Review Expert for the 2026 Philippine Guidelines on Dyslipidemia and Primary Prevention.
A Board-Certified Internist and Fellow of the Philippine College of Physicians, he is a member of the Philippine LIFECARE Study Group, the European Society of Hypertension, and the Philippine Lipid and Atherosclerosis Society, and is an alumnus of the BIHS Emerging Hypertension Leaders Programme (Cambridge, 2025).
His research spans cardiometabolic epidemiology, acute heart failure, hypertension, dyslipidemia, and clinical outcomes research in Philippine tertiary hospital settings. He has authored and co-authored over 15 studies and has received recognition including the PCP INSPIRE 2026 Most Outstanding Research Award and the APSAVD 2026 Young Investigator Award — both for his work on body shape index and cardiometabolic risk in the Philippine LIFECARE cohort.
He also serves as an Evidence Review Expert for the 2026 Philippine Guidelines on Dyslipidemia and Primary Prevention.
Specialty
Internal Medicine